Search Results - Peltec, S

  • Showing 1 - 10 results of 10
Refine Results
  1. 1
    Application of ellipsometry, spr-technic and raman-spectroscopy into diagnosis of colorectal cancer

    Application of ellipsometry, spr-technic and raman-spectroscopy into diagnosis of colorectal cancer by Kruchinina, M V, Gromov, A A, Prudnikova, Y I, Generalov, V M, Kruchinin, V N, Volodin, V A, Shuvalov, G V, Minin, O V, Shehovtsov, S V, Peltec, S E, Minin, I V

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    P41

    P41 by Kruchinina, M, Starikov, A, Kurilovich, S, Kruchinin, V, Volodin, V, Rykhlitskii, S, Gromov, A, Peltec, S, Shehovtsov, S, Generalov, V

    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    P41: Role of the optical methods for blood study in staging of colorectal cancer

    P41: Role of the optical methods for blood study in staging of colorectal cancer by Kruchinina, M., Starikov, A., Kurilovich, S., Kruchinin, V., Volodin, V., Rykhlitskii, S., Gromov, A., Peltec, S., Shehovtsov, S., Generalov, V.

    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Multiparametric ultrasound as a new concept of assessment of liver tissue damage

    Multiparametric ultrasound as a new concept of assessment of liver tissue damage by Peltec, Angela, Sporea, Ioan

    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  5. 5
    Endothelial dysfunction in nonalcoholic fatty liver disease

    Endothelial dysfunction in nonalcoholic fatty liver disease by PELTEC, Angela, ALNABGHALIE, Murad

    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    P1005 : Is aspirin use a protector factor of Nonalcoholic Fatty Liver Disease?

    P1005 : Is aspirin use a protector factor of Nonalcoholic Fatty Liver Disease? by Peltec, A, Ivanov, V, Curocichin, G, Munteanu, A, Dumbrava, V

    Published in Journal of hepatology
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    1357 MAY HEMOGLOBIN BE A MEDIATOR OF INCREASED CARDIOVASCULAR RISK IN NAFLD?

    1357 MAY HEMOGLOBIN BE A MEDIATOR OF INCREASED CARDIOVASCULAR RISK IN NAFLD? by Peltec, A, Ivanova, V, Dumbrava, V, Popovici, M

    Published in Journal of hepatology
    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    861 HOW DOES ELEVATED GAMMA-GLUTAMYLTRANSFERASE ACTIVITY INFLUENCE CARDIOVASCULAR RISK PROFILE IN PATIENTS WITH LIVER STEATOSIS?

    861 HOW DOES ELEVATED GAMMA-GLUTAMYLTRANSFERASE ACTIVITY INFLUENCE CARDIOVASCULAR RISK PROFILE IN PATIENTS WITH LIVER STEATOSIS? by Peltec, A, Ivanov, V, Pereteatco, A, Dumbrava, V, Popovici, M

    Published in Journal of hepatology
    Get full text
    Article
    Save to List
    Saved in:
  9. 9
    365 IS TYPE OF STEATOHEPATITES INFLUENCE THE CARDIOVASCULAR AND DIABETUS MELLITUL RISK PROFILE?

    365 IS TYPE OF STEATOHEPATITES INFLUENCE THE CARDIOVASCULAR AND DIABETUS MELLITUL RISK PROFILE? by Peltec, A, Ivanov, V, Pereteatco, A, Calin, L, Dumbrava, V

    Published in Journal of hepatology
    Get full text
    Article
    Save to List
    Saved in:
  10. 10
    The impact of liver steatosis on the postoperative evolution after right lobe living-donor hepatectomy

    The impact of liver steatosis on the postoperative evolution after right lobe living-donor hepatectomy by Peltec, Angela, Hotineanu, Adrian, Popescu, Irinel, Braşoveanu, Vladislav

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: